A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Clinical trial NCT05358886 · COMPLETED

Trial details

NCT number: NCT05358886
Sponsor: Tetra Discovery Partners
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2022-11-01
Primary completion: 2025-07-18
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.